We are live on ! Find out more
NNNN

Anbio Biotechnology

16.64 USD
+0.78
4.92%
At close Updated Jun 18, 4:00 PM EDT
Pre-market
After hours
16.65
+0.01
0.06%
1 day
4.92%
5 days
1.34%
1 month
-40.89%
3 months
-20.53%
6 months
-44.99%
Year to date
-43.55%
1 year
43.94%
5 years
188.39%
10 years
188.39%
 

About: Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Employees: 27

0
Funds holding %
of 8,101 funds
Positive news %
Price charts implemented using Lightweight Charts™